← Evidence map

ArticleThe Journal of allergy and clinical immunology2023

CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma.

Marc Gauthier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

42 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36893862